Optimer Pharmaceuticals, Inc. Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JERSEY CITY, N.J., May 9, 2013 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013.
Financial Highlights
•First quarter 2013 DIFICID net product sales in the U.S. and Canada of $16.8 million, compared to $14.4 million in 2012
Help employers find you! Check out all the jobs and post your resume.
JERSEY CITY, N.J., May 9, 2013 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013.
Financial Highlights
•First quarter 2013 DIFICID net product sales in the U.S. and Canada of $16.8 million, compared to $14.4 million in 2012
Help employers find you! Check out all the jobs and post your resume.